Your browser doesn't support javascript.
loading
Protocol for ex vivo culture of patient-derived tumor fragments.
Roelofsen, Lisanne M; Voabil, Paula; de Bruijn, Marjolein; Herzig, Petra; Zippelius, Alfred; Schumacher, Ton N; Thommen, Daniela S.
Afiliação
  • Roelofsen LM; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Voabil P; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Bruijn M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Herzig P; Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Zippelius A; Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Schumacher TN; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Hematology, LUMC, Leiden, the Netherlands.
  • Thommen DS; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: d.thommen@nki.nl.
STAR Protoc ; 4(2): 102282, 2023 May 06.
Article em En | MEDLINE | ID: mdl-37149855
ABSTRACT
The lack of suitable models currently hampers our understanding of how the tumor microenvironment responds to immunotherapy treatment. Here, we present a protocol for ex vivo culture of patient-derived tumor fragments (PDTFs). We describe the steps for tumor collection, generation and cryopreservation of PDTFs, and their subsequent thawing. We detail culture of PDTFs and their preparation for analysis. This protocol preserves the tumor microenvironment's composition, architecture, and cellular interactions, which can be perturbed by ex vivo treatment. For complete details on the use and execution of this protocol, please refer to Voabil et al. (2021).1.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article